Dark Forest Capital Management LP cut its stake in shares of Danaher Co. (NYSE:DHR – Free Report) by 38.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,231 shares of the conglomerate’s stock after selling 778 shares during the quarter. Dark Forest Capital Management LP’s holdings in Danaher were worth $283,000 at the end of the most recent reporting period.
A number of other hedge funds also recently made changes to their positions in DHR. Howard Capital Management Group LLC grew its stake in shares of Danaher by 4.1% during the 3rd quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock valued at $342,000 after acquiring an additional 48 shares during the period. Tudor Financial Inc. bought a new position in shares of Danaher during the 3rd quarter valued at approximately $414,000. Anchor Investment Management LLC grew its stake in shares of Danaher by 1.3% during the 3rd quarter. Anchor Investment Management LLC now owns 6,039 shares of the conglomerate’s stock valued at $1,679,000 after acquiring an additional 78 shares during the period. World Investment Advisors LLC boosted its stake in Danaher by 5.3% in the 3rd quarter. World Investment Advisors LLC now owns 12,948 shares of the conglomerate’s stock worth $3,600,000 after purchasing an additional 648 shares during the period. Finally, Arvest Bank Trust Division purchased a new stake in Danaher during the 3rd quarter valued at approximately $254,000. 79.05% of the stock is currently owned by institutional investors.
Insider Buying and Selling at Danaher
In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 11.10% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
Read Our Latest Stock Report on Danaher
Danaher Stock Down 0.6 %
Shares of DHR opened at $196.01 on Tuesday. The company has a market cap of $140.28 billion, a PE ratio of 37.12, a P/E/G ratio of 2.66 and a beta of 0.86. The business has a fifty day moving average of $200.69 and a 200 day moving average of $223.46. Danaher Co. has a 52-week low of $171.00 and a 52-week high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31.
Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. The firm had revenue of $5.74 billion for the quarter, compared to analysts’ expectations of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. On average, sell-side analysts expect that Danaher Co. will post 7.63 EPS for the current year.
Danaher Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, April 25th. Shareholders of record on Friday, March 28th were given a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.65%. This is a boost from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend was Friday, March 28th. Danaher’s payout ratio is 24.85%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
See Also
- Five stocks we like better than Danaher
- The Role Economic Reports Play in a Successful Investment Strategy
- Best Defense Stocks in 2025… So Far
- Why Invest in High-Yield Dividend Stocks?
- Alphabet Rebounds After Strong Earnings and Buyback Announcement
- Using the MarketBeat Stock Split Calculator
- Could Selling Taiwan Semiconductor Be Buffett’s Biggest Regret?
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.